1. Introduction {#sec-1}
===============

World-wide increased antibiotic resistance is a global threat to the health system. Recently, carbapenem-resistant gram-negative bacteria have become quite another multiresistant infectious agent with limited treatment options. Carbapenem-resistant *Klebsiella pneumonia* (CR-KP) hydrolyses carbapenems via β-lactamase enzyme and thus shows resistance to many antimicrobial agents \[1,2\]. Unfortunately, these organisms also have resistance mechanisms for the second line antibiotics. In some recent studies, it has been demonstrated that they may also show resistance to the last option antibiotics such as tigecycline and colistin \[3--5\]. The importance of antibiotic stewardship in the management of patients has been highlighted and practical guidelines have been developed for the benefit of clinicians for the treatment of urinary tract infections (UTIs) \[6,7\].

Patients hospitalized in the urology clinic are estimated to have a hospital-related global infection rate of 10%--12% \[8\]. UTI is the most common type of infection in urology practice, with an annual global case number of approximately 150--250 million \[9\]. UTIs are a major cause of antibiotic use and resistance due to their high prevalence \[10\]. However, risks associated with urological procedures can be reduced by appropriate and effective antibiotic regimens.

Patients hospitalized in the urology clinic have a higher rate of urinary catheterization than other clinics and most of these patients undergo urological surgery. On the other hand, urinary catheterization and surgery are well-known risk factors for infection \[11\]. CR-KP infections encountered in urology patients differentiate from infections caused by other factors, both in prophylaxis and treatment stage, and require a special approach. UTIs caused by CR-KPs are often poor prognostic and difficult to treat \[12,13\].

In the literature, numerous review and meta-analysis are available related to trends in urological infection resistance, their effect on the urological procedures and in regard to antibiotics used. In this controlled trial, we aimed to analyse the factors in the emergence of CR-KP infections in a high-volume urology clinic.

2. Materials and methods {#sec-2}
========================

2.1. Patient selection and data collection {#sec-2-1}
------------------------------------------

Between June 2016 and January 2019, 81 patients who were treated in our clinic and had a CR-KP in urine culture and 151 patients without CR-KP were the subjects of this study. All patients with CR-KP infection, in that period, were included in the study. The control group consisted of patients who were treated for different reasons in our clinic and had no CR-KP infection in the same period. Six patients whose data were not able to reach in the CR-KP group and 5 patients in the non-CR-KP group were excluded from the study, and the remaining 221 patients were included in the study. The study flowchart is shown in Figure 1.

![Study flow-chart.](turkjmedsci-50-239-fig001){#F1}

Demographic data of the patients, operations, duration of hospitalization, presence of a Foley catheter, double J stent and nephrostomy tube, duration of catheterization, complaints at admission, isolated agents in a urine culture, duration of treatment, the antibiotherapies, reinfection rate and treatment of reinfection and isolated agents were recorded from patient files. The data were compared between the 2 groups and the factors that make a significant difference in the development of CR-KP infection among the 2 groups were evaluated. All phases of the study were carried out in accordance with the Declaration of Helsinki or its subsequent amendments. The study protocol was approved by the hospital ethics committee (decision number: 19-5.2T/40 and decision date: 29.05.2019). All patients participating in the study gave written approval for the procedures to be performed.

2.2. Microbiological methods {#sec-2-2}
----------------------------

The minimum inhibitory concentration (MIC) is the lowest antibiotic concentration that inhibits the growth of a particular microorganism for a specific antibiotic. Antimicrobial sensitivity to meropenem and ertapenem is described as follows; resistant, MIC ≥ 16 mg/mL and MIC ≥ 8 mg/L, respectively (for Klebsiella). Sensitivity was defined for colistin, as susceptible, MIC ≤ 0.5 mg/mL (for Klebsiella).

2.3. Outcome measures {#sec-2-3}
---------------------

The primary endpoint of the study was the comparison of predisposing factors between the 2 groups leading to CR-KP infection. The secondary endpoint was a comparison of the reinfection rate and the antibiotherapies in the 2 groups.

2.4. Statistical analysis {#sec-2-4}
-------------------------

The means of 2 groups were compared with independent samples t-test. The chi-square tests were used for testing relationships between categorical variables. The pearson chi-square statistic was used in the test of independence. The Mann--Whitney U test is used to compare differences between 2 independent groups when the dependent variable is either ordinal or continuous, but not normally distributed. Logistic regression analysis was performed for variables that were significant in univariate analysis and predictive factors for CR-KP infection development were evaluated. P values that were considered significant in univariate and multivariate analysis were 0.05 and 0.2, respectively. All statistical analysis was performed with the SPSS statistical software program version 22.0 (IBM Corp., Armonk, NY, USA).

3. Results {#sec-3}
==========

Data of 221 patients were analysed. CR-KP infection was positive in 75 patients, while 146 patients were in the CR-KP negative group. In Group I, the comorbidity rate was higher than Group II (40.0% vs 16.4%, P = 0.001). No significant difference was observed between the 2 groups in terms of proportion of endourologic operations, while the proportion of open operations was higher in Group II (17.3% vs. 32.9%, P = 0.029). Antibiotic use prior to hospitalization was significantly higher in the first group (37.3% vs 16.4%, P = 0.004). There was no significant difference between 2 groups in terms of urological diseases (P \> 0.05). In the first group, the rate of private toilet in the hospital room was higher (21.3% vs. 6.8%, P = 0.012). While no significant difference was observed in terms of Foley catheter and double J stent rate, the nephrostomy tube rate was higher in the first group (34.7% vs 4.1%, P \< 0.001). Complaints associated with flank pain, lower urinary tract symptoms and haematuria were higher in the second group (2.7% vs 28.8%, P \< 0.001; 4.0% vs 27.4%, P \< 0.001; 4.0% vs 17.8%, P = 0.007, respectively). Comparison of demographic data, comorbidities and presentation complaints among the groups is summarized in Table 1.

###### 

Comparison of demographic data, comorbidities and complaints at admission of the CRE positive and negative patients.

  ------------------------------------- ----------------- ------------------- ---------
  Variables                             Group I(n = 75)   Group II(n = 146)   P-value
  Age                                   64.7 ± 13.2       58.8 ± 15.5         0.015
  Comorbidity                           30 (40)           24 (16.4)           0.001
  Diabetes mellitus                     8 (10.7)          10 (6.8)            0.412
  Operation history                     34 (45.3)         72 (49.3)           0.628
  Open urological surgery history       13 (17.3)         48 (32.9)           0.029
  Antibiotic use                        28 (37.3)         24 (16.4)           0.004
  Urological diseases                                                         
  Bladder tumour                        28 (37.3)         44 (30.1)           0.355
  Kidney tumour                         5 (6.7)           16 (11)             0.356
  Benign prostatic hyperplasia          7 (9.3)           8 (5.5)             0.372
  Prostate cancer                       15 (20)           18 (12.3)           0.206
  Ureteral stone                        7 (9.3)           18 (12.3)           0.557
  Kidney stone                          5 (6.7)           16 (11)             0.356
  Urethral stricture                    10 (13.3)         18 (12.3)           0.855
  Fournier gangrene                     2 (2.7)           4 (2.7)             0.978
  Hydronephrosis                        13 (17.3)         26 (17.8)           0.970
  Private toilet in the hospital room   16 (21.3)         10 (6.8)            0.012
  Urological catheter                                                         
  Foley catheter                        65 (86.7)         130 (89)            0.659
  Double J stent                        28 (37.3)         38 (26)             0.140
  Nephrostomy tube                      26 (34.7)         6 (4.1)             \<0.001
  Complaints at admission                                                     
  Flank pain                            2 (2.7)           42 (28.8)           \<0.001
  Lower urinary tract symptoms          3 (4)             40 (27.4)           \<0.001
  Haematuria                            3 (4)             26 (17.8)           0.007
  ------------------------------------- ----------------- ------------------- ---------

Values are given as mean ± standard deviation or number (%) Group I: Carbapenem resistant enterobacteriaceae positive patients; Group II: Carbapenem resistant enterobacteriaceae negative patients. Significant P values are given in bold and italics.

In the first group, the proportion of patients underwent transurethral bladder tumour resection was significantly higher (27% vs 13.7%, P = 0.045), while the proportion of patients underwent percutaneous nephrolithotomy was higher in the second group (2.7% vs 11%, P = 0.045). The comparison of the groups according to the implemented operations is given in Table 2.

###### 

The comparison of the groups according to the operations.

  ---------------------------------------- ----------------- ------------------- ---------
  Operation                                Group I(n = 75)   Group II(n = 146)   P-value
  Endoscopic operations                                                          
  Transurethral bladder tumour resection   20 (27)           20 (13.7)           0.045
  Ureterorenoscopy                         8 (10.7)          16 (11)             0.954
  Endoscopic internal urethrotomy          9 (12)            28 (19.2)           0.228
  Percutaneous nephrolithotomy             2 (2.7)           16 (11)             0.045
  Double J stent implementation            13 (17.3)         20 (13.7)           0.542
  Open operations                                                                
  Fournier's gangrene debridement          3 (4)             4 (2.7)             0.671
  Radical cystectomy + urinary diversion   6 (8)             4 (2.7)             0.157
  Radical nephrectomy                      2 (2.7)           10 (6.8)            0.231
  Partial nephrectomy                      2 (2.7)           6 (4.1)             0.627
  Retropubic radical prostatectomy         8 (10.7)          8 (5.5)             0.248
  ---------------------------------------- ----------------- ------------------- ---------

Values are given as number (%) Group I: Carbapenem resistant enterobacteriaceae positive patients; Group II: Carbapenem resistant enterobacteriaceae negative patients. Significant P values are given in bold and italics.

There was a significant difference between the 2 groups in terms of hospitalization, Foley catheter, double J stent, and nephrostomy duration (P \< 0.001, P \< 0.001, P \< 0.001, and P = 0.005, respectively). While the mean leukocyte count was significantly higher in the first group (P \< 0.001), there was no significant difference between the 2 groups in terms of mean C-reactive protein (CRP) value at admission (P = 0.288). Foley catheter duration was longer in the first group, while the double J stent and nephrostomy tube durations were longer in the second group. The comparison of hospitalization and catheter durations and mean leukocyte and CRP values are shown in Table 3 and Figure 2.

###### 

The comparison of hospitalization and catheter durations and leukocyte and CRP values.

  --------------------------------- --------------------- ------------------- ---------
  Variables                         Group I(n = 75)       Group II(n = 146)   P-value
  Hospitalization duration          8.83 ± 9.24           3.40 ± 3.86         \<0.001
  Foley catheter duration           7.62 ± 7.70           3.45 ± 4.23         \<0.001
  Double J stent duration           28.14 ± 74.31         91.11 ± 123.24      \<0.001
  Nephrostomy duration              36.51 ± 93.78         253.33 ± 193.41     0.005
  Leukocyte count at admission      10,931.49 ± 5061.90   8211.13 ± 3602.82   \<0.001
  C-reactive protein at admission   9.67 ± 8.64           5.23 ± 4.84         0.288
  --------------------------------- --------------------- ------------------- ---------

Values are given as mean ± standard deviation. Group I: Carbapenem resistant enterobacteriaceae positive patients; Group II: Carbapenem resistant enterobacteriaceae negative patients. Significant P values are given in bold and italics.

![The comparison of hospitalization, foley catheter, double j stent, and nephrostomy tube durations.](turkjmedsci-50-239-fig002){#F2}

In the CR-KP negative group, urine culture was positive in 18 patients (12.3%) and 4 of them were *Klebsiella pneumonia* (2.7%). In this group, 140 patients received treatment (95.9%). Antibiotics used in the second group are shown in Figure 3. The most frequently used antibiotic periods were 1-day (20.9%) and 5-day (7.4%) intervals, respectively. None of the patients in this group had a fever of more than 38 °C and reinfection.

![Antibiotics used in CRE negative group.](turkjmedsci-50-239-fig003){#F3}

In the CR-KP positive group, 8 patients presented with fever (10.7%) and 3 patients with sepsis (4%). The urine culture of 74 patients was positive and the isolated agents were CR-KPs in all of them. Treatment was initiated on 80% of the patients (n = 60) and antibiotherapies are summarized in Figure 4. The most common preferred treatments were Meropenem + Daptomycin (26.9%) and Meropenem + Ertepenem (25.2%) combinations. The most common treatment period was 14-day interval in 18.9% of the patients. Reinfection was seen in 20 of these patients (26.7%). In all, the isolated agent in the urine culture was *Klebsiella pneumonia*. Five (25%) had a fever of more than 38 °C. Sixteen (80%) had urological intervention before reinfection and 11 of them were open surgeries (68.7%). Meropenem was used in 49 patients (65.3%) and all of them were drug-resistant (MIC ≥ 16 mg/mL). Ertapenem was used in 35 patients (46.7%) and all of 35 were drug-resistant (MIC ≥ 8 mg/mL). Colistin was used in 14 patients (16.9%) and all were susceptible to the drug (MIC ≤ 0.5 mg/mL).
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In the multivariate analysis, age, comorbidity, private toilet in the hospital room, Foley catheter duration, presence of nephrostomy, and complaints on admission were significantly different between the 2 groups. Multivariate analysis of predisposing factors for CR-KP infection is shown in the Table 4.

###### 

Multivariate analysis of predisposing factors for CRE infection.

  ---------------------------------------- --------- --------------------- ------- --------
  Variables                                          95% C.I. for EXP(B)           
  Sig.                                     Exp(B)    Lower                 Upper   
  Age (years)                              0.018     1.029                 1.005   1.054
  Comorbidity                              0.002     3.389                 1.565   7.336
  Diabetes mellitus                        0.416     1.624                 0.505   5.217
  Endourologic operation history           0.543     1.321                 0.539   3.236
  Urethral stricture                       0.855     1.094                 0.417   2.870
  Fournier gangrene                        0.978     0.973                 0.133   7.094
  Hydronephrosis                           0.970     0.984                 0.422   2.295
  Fournier gangrene debridement            0.673     1.479                 0.240   9.120
  Radical cystectomy + urinary diversion   0.176     3.087                 0.602   15.822
  Private toilet in the hospital room      0.016     3.688                 1.274   10.677
  Foley catheter                           0.659     0.800                 0.297   2.156
  Foley catheter duration                  0.002     1.118                 1.043   1.199
  Double J stent                           0.623     1.215                 0.559   2.639
  Double J stent duration                  0.737     1.001                 0.996   1.005
  Nephrostomy                              \<0.001   12.381                3.549   43.197
  Nephrostomy duration                     0.072     1.005                 1.000   1.011
  Complaints at admission                  \<0.001   10.500                4.908   22.462
  ---------------------------------------- --------- --------------------- ------- --------

Significant P values are given in bold and italics.

The most common interval from the urological surgery to CR-KP positivity was a 60-day interval, in 17.9% of the patients, and the second most common interval was 30-day, in 11.9% of the patients. On the other hand, the most common interval from hospitalization to CR-KP positivity was 60-day, in 18.7% of the patients, and secondly 30-day in 10.7% of the patients.

4. Discussion {#sec-4}
=============

Carbapenem resistance in *Enterobacteria*, which is mainly associated with the mechanisms associated with plasmid-encoded carbapenemases, is an increasing and important global health problem \[14--16\]. Excessive consumption of carbapenems used to treat extended spectrum beta-lactamase (ESBL) gram-negative infections has led to increased carbapenem resistance, particularly for *E.coli* and *Klebsiella*, which are responsible for the majority of urological infections. However, the significant cost of treatment, prolonged hospitalization and loss of the labour force have emerged.

Patients with indwelling catheters constitute major reservoirs for multi-resistant bacteria. The catheter-associated UTI may be formed by the extraluminal route through the bacteria entering the bladder from the biofilm formed around the catheter in the urethra or intraluminal route by the urinary stasis caused by drainage failure or ascending infection with contamination of the urine collection reservoir \[17\]. It is known that the duration of catheterization is the most important risk factor for bacteriuria \[18\]. In patients with indwelling catheter, bacteriuria occurs at a rate of 3%--10% per day of catheter \[19\]. In our study, we found that patients with Foley catheter and nephrostomy tube had more CR-KP infections and the duration of catheterization was significantly extended in these patients. We could not show a similar effect for the double J stent. Long-term Foley catheterization and nephrostomy tube may be an important risk factor for CR-KP infections by extraluminal route and minimizing the duration of Foley catheter and nephrostomy in these patients may be an effective method to prevent these infections.

High urolithiasis incidence, lower urinary tract symptoms and history of urinary infection, and prolonged use of antibiotics as a result of these are considered as the responsible factors for the development of antibiotic resistance in urological patients \[20\]. In addition, a patient in the urology clinic has a possibility of having a urological operation of approximately 75%, of which 55% are endourological operations \[21\]. In non-urological clinics, urinary infections constitute 15%--57% of hospital-acquired infections, while this rate is 70% in urology clinics \[21,22\]. In our study, there was no significant difference in the prevalence of renal and ureteral stones between the 2 groups. Since our country is located in an endemic region for stone disease and our clinic is a reference centre for stone patients in the region, a large number of stone patients are being treated. Therefore, no significant difference might be observed between the 2 groups. The history of antibiotic use, which is a reflection of previous infections, was found to be higher in the first group, a possible cause of carbapenem resistance. There was also a significant difference between the 2 groups in terms of the operation type, as follows: in the first group, the prevalence of open operation was lower and the prevalence of transurethral bladder tumour resection which is an endourologic operation was higher. Shorter Foley catheter duration in open operations and longer catheterization duration due to resection of large and necrotic bladder tumours and recurrent haematuria attacks may be responsible from this difference.

Age and comorbidities such as immunosuppression, diabetes, obesity, liver dysfunction and malnutrition are well known risk factors for hospital-acquired infections \[23\]. In our study, we found that the first group consisted of older and more comorbid patients in accordance with this data.

In areas with high antibiotic resistance, antibiotics such as fosfomycin, nitrofurantoin, tigecycline, colistin, and carbapenem are recommended for the treatment of UTIs rather than fluoroquinolone \[24\]. Since colistin is nephrotoxic, and it should not be used alone in this infection, because of increasing resistance. The MIC values of microorganisms guide the selection of antibiotics, and preferably the combination with a carbapenem group antibiotic is beneficial. In general, the combination therapy with a carbapenem group antibiotic has been shown to provide a synergistic effect in the treatment of these resistant infections \[25,26\]. The rationale of combination of 2 or more agents is the reduction in the mortality rate caused by severe CR-KP infections, resistance may occur during monotherapy, and insufficient evidence of the effectiveness of monotherapy. In many observational studies, it has been shown that combination therapy can reduce mortality rates \[27,28\]. Therefore, although resistant to all, we preferred antibiotic combinations of carbapenem group containing meropenem and ertapenem in 65% and 46% of our patients, respectively. In a retrospective study of 230 patients, ertapenem was shown to be effective in the treatment of complicated UTIs caused by ESBL-producing microorganisms, and in particular, patients undergoing urinary catheterization, urologic intervention and those with diabetes were under risk for superinfection \[29\]. If the isolate is susceptible, polymyxin-based combination regimens may also be beneficial. In our study, colistin, which was used in approximately one-fifth of patients, was susceptible for all isolates with very low MIC values. However, the transition of tigecycline to urine is 1%, it may also be considered among the second-line treatment agents. Plazomicin is a promising new aminoglycoside antibiotic in the treatment of carbapenemase producing isolates resistant to old aminoglycosides \[30\]. In our study, dual combination therapies were the most preferred treatment protocols for CR-KP infections and 14-day antibiotherapy interval was the most commonly used treatment protocol. The reason for the high rate of reinfection may be the rehospitalization of these patients due to recurrent endourologic interventions such as control cystoscopy and ureteroscopy.

Empirical treatment can be introduced without any urine culture with a carefully taken clinical history for the treatment of UTIs. However, in some areas with high antibiotic resistance or in cases where symptoms are uncertain, the infectious agent should be identified with microbiological analysis. In our study, we found that the group with negative CR-KP infection was more symptomatic (flank pain and lower urinary tract symptoms) than the positive group.

Our study has some limitations. Our retrospective study included a short period of time when CR-KP infections peaked. Secondly, this study, which reflects the results of a single-centre, has a relatively limited number of patients.

In conclusion, CR-KP infection is an increasing problem and necessary precautions should be taken in the urology clinics for prevention and prophylaxis and treatment should be administered with appropriate agents. In particular, advanced age, comorbidities, previous antibiotic use, transurethral resection, long-term Foley catheterization are important risk factors for these infections. Notably, the two-week combination of glycopeptide and lipopeptide antibiotics with carbapenem group antibiotics appears to be an effective treatment method for CR-KP infections. The etiopathogenesis of CR-KP infections in urology patients may be better clarified in controlled-prospective studies conducted with large patient groups.
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